Like SARS, Ebola, and other
|
|
- Clement Gordon
- 6 years ago
- Views:
Transcription
1 Policy Forum Open access, freely available online Agricultural Antibiotics and Human Health Does antibiotic use in agriculture have a greater impact than hospital use? David L. Smith*, Jonathan Dushoff, J. Glenn Morris, Jr. Like SARS, Ebola, and other emerging infectious diseases, antibiotic resistance in bacteria may have a zoonotic origin [1]. Evidence suggests that antibiotic use in agriculture has contributed to antibiotic resistance in the pathogenic bacteria of humans, but the chain from cause to effect is long and complicated. Antibiotic use clearly selects for antibiotic resistance, but how far do these effects extend beyond the population where antibiotics are used? Antibiotics and antibiotic-resistant bacteria (ARB) are found in the air and soil around farms, in surface and ground water, in wild animal populations, and on retail meat and poultry [2 9]. ARB are carried into the kitchen on contaminated meat and poultry, where other foods are cross-contaminated because of common unsafe handling practices [10,11]. Following ingestion, bacteria occasionally survive the formidable but imperfect gastric barrier, and colonize the gut [12]. Patterns of colonization (asymptomatic carriage) and infection (symptomatic carriage) in human populations provide additional evidence that ARB occasionally move from animals to humans [13,14]. The strongest evidence comes from the history of the use of antibiotics for growth promotion in Europe. After first Denmark and then the European Union banned the use of antibiotics for growth promotion, prevalence of resistant bacteria declined in farm animals, in retail meat and poultry, and within the general human population [8,15]. Despite the evidence linking bacterial antibiotic resistance on farms to resistance in humans, the impact of agricultural antibiotic use remains controversial [16 19] and poorly The Policy Forum allows health policy makers around the world to discuss challenges and opportunities for improving health care in their societies. Summary Points The emergence and spread of ARB is complex and intrinsically difficult to study; mathematical models can help with understanding underlying mechanisms and guiding policy responses. Agricultural antibiotic use may generate novel types of ARB that spread to the human population; models can help estimate how much additional disease has been caused by agricultural antibiotic use. Transmission of ARB from animal to human populations is particularly difficult to measure, as it is the product of a very high exposure rate to potentially contaminated food, and a very low probability of transmission at any given meal. Depending on the assumptions used, the model suggests that transmission from agriculture can have a greater impact on human populations than hospital transmission. A comparison of patterns of colonization of VRE in Europe and the United States, which had different patterns of agricultural and hospital antibiotic use, suggests that agricultural antibiotic use can have important quantitative effects on the spread of resistance in the community. quantified. This is partly because of the complex of population-level processes underlying the betweenspecies ( heterospecific ) and withinspecies, host-to-host ( horizontal ) spread of ARB. To emerge as human pathogens, new strains of ARB must (1) evolve, originating from mutations or gene transfer; (2) spread, usually horizontally among humans or animals, but occasionally heterospecifically; and (3) cause disease. All three of these steps are complex and imperfectly understood. The emergence of a new type of resistance is a highly random event, which can t be predicted accurately, and may involve multiple steps that preclude perfect understanding even after the fact. Spread is equally complicated and may obscure the origins of resistance. In some cases, emergence of resistance in one bacterial species is a consequence of the emergence and spread in another species, followed by the transfer of resistance genes from one bacterial species to another. Because of the underlying complexity, mathematical models are necessary to develop theory a qualitative understanding of the underlying epidemiological processes [20 25]. Theory helps researchers organize Citation: Smith DL, Dushoff J, Morris G Jr (2005) Agricultural antibiotics and human health. PLoS Med 2(8): e232. Copyright: This is an open-access article distributed under the terms of the Creative Commons Public Domain Declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. Abbreviations: ARB, antibiotic-resistant bacteria; VRE, vancomycin-resistant enterococci David Smith is a mathematical epidemiologist and infectious disease ecologist at Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America. Jonathan Dushoff is on the research staff in the Department of Ecology and Evolutionary Biology at Princeton University, Princeton, New Jersey, United States of America, and at Fogarty International Center, National Institutes of Health. J. Glenn Morris, Jr., is a physician epidemiologist and specialist in infectious diseases, and chair of the Department of Epidemiology and Preventive Medicine in the School of Medicine, University of Maryland, Baltimore, Maryland, United States of America. The views presented in this paper represent the personal views of the authors and do not construe or imply any official position or policy of the Fogarty International Center, National Institutes of Health, Department of Health and Human Services, or the US government. *To whom correspondence should be addressed. smitdave@helix.nih.gov Competing Interests: DLS and JGM received funding four years ago from Pfizer to conduct a risk assessment for the emergence of streptogramin resistance in Enterococcus faecium. JD declares that he has no competing interests. DOI: /journal.pmed PLoS Medicine
2 facts, identify missing information, design surveillance, and analyze data [26]. Horizontal Transmission Theory clearly shows that the impact of agricultural antibiotic use depends on whether resistant bacteria have high, low, or intermediate horizontal transmission rates in human populations [23,24]. The rate of horizontal transmission among humans is determined by the underlying biology of the pathogen, medical antibiotic use, and hospital infection control, but not by agricultural antibiotic use [22]. On the other hand, a farm where multiple antibiotics are used routinely, universally, and in low quantities for growth promotion is likely to be an excellent environment for the evolution of multiple resistance factors, including some variants that might never have evolved in humans. Thus, even very rare transmission resulting from agricultural antibiotics may have a medical impact by introducing new resistant variants to the human population. The epidemiology of spread in the human population dictates how the impact of agricultural antibiotic use should be assessed. Zoonotic pathogens, such as Campylobacter and Salmonella, are generally regarded as having low horizontal transmission rates in human populations. While resistance in zoonotic infections should be directly attributable to resistance in the zoonotic reservoir, the impact of agricultural antibiotic use remains controversial [18,27 29]. Zoonotic species could acquire resistance genes from human commensal bacteria during the infection process, but this hypothesis is difficult to test. For pathogens with high horizontal transmission rates, resistant bacteria will spread rapidly once they have emerged, and prevalence will be maintained at a steady state by horizontal transmission. Thus, the impact of subsequent heterospecific transmission is limited (Figure 1). Nevertheless, one or two heterospecific transmission events could be sufficient to cause the appearance of a highly successful ARB genotype in humans, affecting the timing, nature, and extent of spread within the human population [22]. Not only are such events difficult to trace, but their impact is impossible to measure, since there is no way to know what type of resistance would have appeared and with what temporal pattern, if transfers from animals had been prevented. The case where horizontal human transmission rates are intermediate is particularly interesting. If each case in a population generates approximately one new case (a situation we call quasi-epidemic transmission), each instance of heterospecific transmission will initiate a long chain of horizontal transmission that eventually burns out. Quasi-epidemic transmission can amplify a relatively low amount of heterospecific transmission and substantially increase prevalence [23 25]. The effect is sustained as long as heterospecific transmission continues. A corollary is that banning agricultural antibiotic use would have maximal benefits if horizontal transmission is quasi-epidemic [24]. Moreover, the effects are most difficult to estimate because both heterospecific and horizontal transmission must be accounted for. DOI: /journal.pmed g001 Figure 1. The Emergence and Spread of Antibiotic Resistance in Bacteria with High Horizontal Transmission Rates Emergence and spread begins with a honeymoon period following the approval of a new antibiotic; the honeymoon ends when resistance emerges. Prevalence increases exponentially at first, but it eventually approaches a steady state. The impact of agricultural antibiotic use must be assessed by comparing the observed situation with the counterfactual situation, an imaginary world in which antibiotics were never used in agriculture. The impact of agricultural antibiotic use is, then, the total number of cases of resistance that would not have happened without the use of antibiotics in agriculture. This is approximately the difference between the time of actual emergence and the counterfactual emergence, multiplied by the steady-state prevalence. While we don t know what would have happened in any particular case, we can estimate the likely magnitude of agricultural impacts. These principles apply to bacteria associated with outpatient antibiotic use and community-acquired infections as well as those that are primarily hospitalacquired. Although quasi-epidemic transmission would seem to be a special case, it may in fact be the rule for many hospital-acquired bacteria because it is the natural endpoint of the interplay between economics and ecology [30]. By spending money on hospital infection control, hospital administrators can reduce nosocomial transmission rates for resistant bacteria. For example, hospitals may screen and isolate patients who are likely to be carriers (i.e., active surveillance) and implement infection-control measures, but this comes at the cost of isolating patients [31]. Total costs are minimized by spending just enough to eliminate (or nearly eliminate) the pathogen; thus, quasi-epidemic transmission is the economic optimum [30]. The Community as a Reservoir for Resistance Horizontal transmission is further complicated by population structure, such as the movement of humans through hospitals and long-term care facilities. Medical antibiotic use and horizontal transmission rates are high in hospitals, but this is counterbalanced by short hospital stays. An emerging view for hospital-acquired bacterial infections is that persistent asymptomatic carriage plays a key role in the epidemic of resistance. ARB can asymptomatically colonize a person for years: even if the number of other people infected during a single hospital visit is less than one, this number will exceed one when summed over several hospital visits [25,32,33]. Thus, the ecological reservoir of resistance in the community plays an important role in the increasing frequency of resistance in hospital-acquired infections. Short hospital visits and long persistence times of ARB in people guarantee that some of the costs associated with failed infection control are passed on to other hospitals new carriers are frequently discharged from one hospital only to be admitted to another hospital later [30]. Thus, the harm done by these ARB is borne by the whole human population, particularly all of the health-care institutions that serve a single catchment population. In economic PLoS Medicine
3 terms, the damage caused by the carriage of ARB is a kind of pollution. By comparing the total number of new carriers generated in the community, the impacts of agricultural antibiotic use on hospitals can be compared directly to the impact hospitals have on each other (Figure 2). The rate of heterospecific transmission is intrinsically difficult to measure directly because the risk of exposure and colonization per meal is very small. Nevertheless, agricultural antibiotic use may generate as many carriers as hospitals for the simple reason that the population experiences many more meals than hospital discharges [34]. When agricultural and nosocomial transmission are equally rare in the population, the latter will be much easier to identify and quantify. A Natural Experiment: Glycopeptides and Vancomycin- Resistant Enterococci Is the impact of agricultural antibiotic use on the emergence and spread of ARB in humans large or small relative to medical antibiotic use? Put another way, are farms or hospitals bigger polluters? A large-scale natural experiment was conducted in the United States and several European countries when each adopted different policies on glycopeptide use in animals (avoparcin) and humans (vancomycin) [16,17,35 37]. Many European countries approved avoparcin for animal growth promotion in the 1970s, but the US did not. In the early 1980s, demand for vancomycin in US hospitals surged because of increasing aminoglycoside resistance among enterococci and methicillin resistance in Staphylococcus aureus. Physicians in US hospitals also used oral vancomycin for some Clostridium difficile infections [37 39]. In the late 1980s and early 1990s, vancomycin-resistant enterococci (VRE) emerged and spread through US health-care systems. In Europe, hospitals used less vancomycin because most enterococci were sensitive to aminoglycosides, and oral vancomycin was seldom used. VRE still emerged and spread through European hospitals, but the problem has been less severe than in the US [40]. A different pattern emerges for community prevalence of VRE. VRE are rarely found outside of hospitals DOI: /journal.pmed g002 Figure 2. How Large Is the Impact of Antibiotic Use in Agriculture? Comparing the amount of antibiotics used in agriculture with the amount used in medicine means comparing fundamentally different things because they affect the emergence of medically important antibiotic resistance in different ways. For hospital-acquired infections, it is more appropriate to think about ARB carriage in the community as a kind of pollution that flows into hospitals. Thus, the appropriate way to measure impact is by counting how many new carriers are added to the community reservoir from hospital discharges versus from exposure to bacteria that originate on farms. Different formulas describe these processes. To count ARB carriers among hospital discharges, let x denote the proportion of patients from a hospital (or other institution) that are colonized on discharge. In some discharged patients, resistant bacteria clear quickly, but a fraction, p, become ARB carriers. Some proportion of patients were already carriers at the time of admission, denoted by k. Institutions vary by size, H, and average length of stay (1/s). Thus, the rate that new carriers are discharged from a hospital is given by the formula: sh( px k ). This formula measures the contribution of a hospital to the number of ARB carriers in the community. For example, a hospital with 400 filled beds (H = 400 people) serves a US population of about 250,000 people. With a five-day average length of stay (the discharge rate is s = 0.2 per patient per day), the hospital discharges about 80 patients each day. If we suppose that 20% of patients acquire resistant bacteria while hospitalized, and one in four of these patients become carriers (px k = 0.05), a hospital would discharge about four persistently colonized people per day about 1,460 carriers after one year, or approximately 0.58% of its catchment population. A different formula characterizes heterospecific transmission, following exposure to ARB on contaminated food. We let g denote the daily per-capita rate that ARB are ingested with a meal. Similarly, we let h denote the proportion of those ARB populations that survive the gastric barrier and persistently colonize. The number of new carriers generated in the community by agricultural antibiotic use in a population of size N is: ghn. For example, if the average person consumes some ARB in 1% of meals (g = 0.03 per person per day), followed by colonization with probability one in 2,000 (h = ), agricultural antibiotic use would generate about four new carriers per day in a population of 250,000 people, N, approximately the same number as a hospital. The formulas illustrate a general principle: A large number of people exposed to a small risk may generate many more cases than a small number exposed to a high risk [34]. in the US, except for patients who have a prior history of hospitalization. Community prevalence of VRE in the US is typically less than 1%. In contrast, community prevalence of VRE was estimated at 2% 12% in Europe during the late 1990s, including carriage by people with no history of hospitalization [17,41 48]. In other words, the European community reservoir generated by vancomycin use in hospitals and avoparcin use in agriculture was apparently much larger than the US community reservoir generated only by vancomycin use in hospitals. The prevalence of VRE in the community declined after the EU banned avoparcin [15]. Thus, avoparcin is at least partly responsible for the reservoir of VRE in the European community, but how much PLoS Medicine
4 of that reservoir came from avoparcin and how much came from hospitals? To weigh the impact, we subtract the community prevalence of VRE in the US (<1%) from the community prevalence of VRE in Europe (>2%). The remainder (>1%) is attributed to avoparcin. This analysis probably underestimates the real impact because vancomycin was used less in European than in US hospitals. Thus, avoparcin use in Europe would appear to be responsible for generating a larger reservoir of VRE in the community than US hospitals. Put another way, the impact of avoparcin use on European hospitals was larger than the impact of US hospitals on one another. Conclusion Despite the evidence that avoparcin use has had a large impact on the emergence and spread of VRE by increasing the reservoir of VRE in the EU, some uncertainty continues to surround the clinical significance of VRE strains of animal origin and of the zoonotic origins of resistance in general. Bacterial strains circulating in hospitalized populations may be genetically distinct from those circulating in the general human population [13,17,49]. Thus, bacterial populations are some combination of zoonotic, quasi-epidemic, and epidemic strains. The complexity of bacterial population biology and It is prudent and reasonable to consider bacteria with resistance genes a general threat. genetics makes it practically impossible to trace bacteria (or resistance factors) from the farm to the hospital, or to directly attribute some fraction of new infections to agricultural antibiotic use. Asymptomatic carriage of resistance factors by nonfocal commensal bacteria adds to a general risk of resistance, but transfer of resistance among bacterial species is unpredictable and difficult to quantify. Until more evidence is available, it is prudent and reasonable to consider bacteria with resistance genes a general threat [50 52]. Some part of the controversy over agricultural antibiotic use has been a disagreement about how to weigh evidence and make decisions when the underlying biological processes are complex. In this case, the effects of agricultural antibiotic use on human health remain uncertain, despite extensive investigation, and the effects may be unknowable, unprovable, or immeasurable by the empirical standards of experimental biology. What should be done when complexity makes an important publichealth effect intrinsically difficult to measure? What is an appropriate null hypothesis or its equivalent? Should the same standards of proof be used in science and science-based policy? Where should the burden of proof fall? Scientific assessments for policy should summarize the best state of the science, recognizing that the burdens and standards of proof are necessarily softer because of the uncertainty that is introduced by biological complexity. The best decisions weigh the evidence in light of the inherent uncertainty. The EU banned the use of antibiotics for growth promotion, based on the precautionary principle. The use of the precautionary principle was criticized by some as unscientific in this context. In fact, the intrinsic problem of knowability, posed by the biological complexity of the problem, makes the use of precautionary decision making particularly suitable in this arena. The assumption that plausible dangers are negligible, even when it is known that such dangers are constitutively very difficult to measure, may be more unscientific than the use of precaution. References 1. Taylor LH, Latham SM, Woolhouse MEJ (2001) Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 356: Hamscher G, Pawelzick HT, Sczesny S, Nau H, Hartung J (2003) Antibiotics in dust originating from a pig-fattening farm: A new source of health hazard for farmers? Environ Health Perspect 111: Zahn JA (2001) Evidence for transfer of tylosin and tylosin-resistant bacteria in air from swine production facilities using sub-therapeutic concentrations of Tylan in feed. J Anim Sci 79: Iversen A, Kuhn I, Rahman M, Franklin A, Burman LG, et al. (2004) Evidence for transmission between humans and the environment of a nosocomial strain of Enterococcus faecium. Environ Microbiol 6: Gilliver MA, Bennett M, Begon M, Hazel SM, Hart CA (1999) Antibiotic resistance found in wild rodents. Nature 401: Osterblad M, Norrdahl K, Korpimaki E, Huovinen P (2001) Antibiotic resistance. How wild are wild mammals? Nature 409: Chee-Sanford JC, Aminov RI, Krapac IJ, Garrigues-Jeanjean N, Mackie RI (2001) Occurrence and diversity of tetracycline resistance genes in lagoons and groundwater underlying two swine production facilities. Appl Environ Microbiol 67: Emborg HD, Andersen JS, Seyfarth AM, Andersen SR, Boel J, et al. (2003) Relations between the occurrence of resistance to antimicrobial growth promoters among Enterococcus faecium isolated from broilers and broiler meat. Int J Food Microbiol 84: Kmmerer K (2004) Resistance in the environment. J Antimicrob Chemother 54: Mattick K, Durham K, Domingue G, Jorgensen F, Sen M, et al. (2003) The survival of foodborne pathogens during domestic washing-up and subsequent transfer onto washing-up sponges, kitchen surfaces and food. Int J Food Microbiol 85: Gorman R, Bloomfield S, Adley CC (2002) A study of cross-contamination of food-borne pathogens in the domestic kitchen in the Republic of Ireland. Int J Food Microbiol 76: Sorensen TL, Blom M, Monnet DL, Frimodt- Moller N, Poulsen RL, et al. (2001) Transient intestinal carriage after ingestion of antibioticresistant Enterococcus faecium from chicken and pork. N Engl J Med 345: Willems RJ, Top J, van den Braak N, van Belkum A, Endtz H, et al. (2000) Host specificity of vancomycin-resistant Enterococcus faecium. J Infect Dis 182: Bruinsma N, Willems RJL, van den Bogaard AE, van Santen-Verheuevel M, London N, et al. (2002) Different levels of genetic homogeneity in vancomycin-resistant and -susceptible Enterococcus faecium isolates from different human and animal sources analyzed by amplified-fragment length polymorphisms. Antimicrob Agents Chemother 46: Aarestrup FM, Seyfarth AM, Emborg HD, Pedersen K, Hendriksen RS, et al. (2001) Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 45: Wegener HC, Aarestrup FM, Jensen LB, Mammerum AM, Bager F (1999) Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg Infect Dis 5: Bonten MJ, Willems R, Weinstein RA (2001) Vancomycin-resistant enterococci: Why are they here, and where do they come from? Lancet Infect Dis 1: Phillips I, Casewell M, Cox T, de Groot B, Friis C, et al. (2004) Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother 53: Jensen VF, Neimann J, Hammerum AM, Molbak K, Wegener HC (2004) Does the use of antibiotics in food animals pose a risk to human health? An unbiased review? J Antimicrob Chemother 54: Bonten MJ, Austin DJ, Lipsitch M (2001) Understanding the spread of antibiotic resistant pathogens in hospitals: Mathematical models as tools for control. Clin Infect Dis 33: Lipsitch M, Singer RS, Levin BR (2002) Antibiotics in agriculture: When is it time to close the barn door? Proc Natl Acad Sci U S A 99: S572 S Smith DL, Harris AD, Johnson JA, Silbergeld EK, Morris JG Jr (2002) Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc Natl Acad Sci U S A 99: Smith DL, Johnson JA, Harris AD, Furuno JP, Perencevich EN, et al. (2003) Assessing risks PLoS Medicine
5 for a pre-emergent pathogen: Virginiamycin use and the emergence of streptogramin resistance in Enterococcus faecium. Lancet Infect Dis 3: Kelly L, Smith DL, Snary EL, Johnson JA, Harris AD, et al. (2004) Animal growth promoters: To ban or not to ban? A risk assessment approach. Int J Antimicrob Agents 24: Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA (2004) Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: Resistance is a regional problem. Proc Natl Acad Sci U S A 101: Becker NG (1989) Analysis of infectious disease data. London: Chapman and Hall. 224 p. 27. Wegener HC, Aarestrup FM, Gerner-Smidt P, Bager F (1999) Transfer of antibiotic resistant bacteria from animals to man. Acta Vet Scand Suppl 92: Aarestrup FM, Engberg J (2001) Antimicrobial resistance of thermophilic Campylobacter. Vet Res 32: Luber P, Wagner J, Hahn H, Bartelt E (2003) Antimicrobial resistance in Campylobacter jejuni and Campylobacter coli strains isolated in 1991 and from poultry and humans in Berlin, Germany. Antimicrob Agents Chemother 47: Smith DL, Levin SA, Laxminarayan R (2005) Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc Natl Acad Sci U S A 102: Perencevich EN, Fisman DN, Lipsitch M, Harris AD, Morris JG Jr, et al. (2004) Projected benefits of active surveillance for vancomycinresistant enterococci in intensive care units. Clin Infect Dis 38: Bonten MJ, Hayden MK, Nathan C, Rice TW, Weinstein RA (1998) Stability of vancomycinresistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis 177: Cooper BS, Medley GF, Stone SP, Kibbler CC, Cookson BD, et al. (2004) Methicillinresistant Staphylococcus aureus in hospitals and the community: Stealth dynamics and control catastrophes. Proc Natl Acad Sci U S A 101: Rose G (1992) The strategy of preventive medicine. Oxford: Oxford University Press. 160 p. 35. Martone WJ (1998) Spread of vancomycinresistant enterococci: Why did it happen in the United States? Infect Control Hosp Epidemiol 19: Cetinkaya Y, Falk P, Mayhall CG (2000) Vancomycin-resistant enterococci. Clin Microbiol Rev 13: Rice LB (2001) Emergence of vancomycinresistant enterococci. Emerg Infect Dis 7: Morris JG Jr, Shay DK, Hebden JN, McCarter RJ Jr, Perdue BE, et al. (1995) Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 123: Kirst HA, Thompson DG, Nicas TI (1998) Historical yearly usage of vancomycin. Antimicrob Agents Chemother 42: Schouten MA, Hoogkamp-Korstanje JA, Meis JF, Voss A, European VRE Study Group (2000) Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 19: van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R (1996) Influence of oral glycopeptides on the fecal flora of human volunteers: Selection of highly glycopeptideresistant enterococci. J Infect Dis 173: Gordts B, van Landuyt H, Ieven M, Vandamme P, Goossens H (1995) Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol 33: Endtz HP, van den Braak N, van Belkum A, Kluytmans JA, Koeleman JG, et al. (1997) Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol 35: Schouten MA, Voss A, Hoogkamp-Korstanje JA (1997) VRE and meat. Lancet 349: van den Braak N, Kreft A, van Belkum D, Verbrugh H, Endtz H (1997) Vancomycinresistant enterococci in vegetarians. Lancet 350: van den Bogaard AE, Mertens P, London NH, Stobberingh EE (1997) High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: Is the addition of antibiotics to animal feeds to blame? J Antimicrob Chemother 40: van den Braak N, van Belkum A, van Keulen M, Vliegenthart J, Verbrugh HA, et al. (1998) Molecular characterization of vancomycinresistant enterococci from hospitalized patients and poultry products in The Netherlands. J Clin Microbiol 36: Stobberingh E, van den Bogaard A, London N, Driessen C, Top J, et al. (1999) Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of The Netherlands: Evidence for transmission of vancomycin resistance from animals to humans? Antimicrob Agents Chemother 43: Leavis HL, Willems RJ, Top J, Spalburg E, Mascini EM, et al. (2003) Epidemic and nonepidemic multidrug-resistant Enterococcus faecium. Emerg Infect Dis 9: Hammerum AM, Fussing V, Aarestrup FM, Wegener HC (2000) Characterization of vancomycin-resistant and vancomycinsusceptible Enterococcus faecium isolates from humans, chickens, and pigs by RiboPrinting and pulsed-field gel electrophoresis. J Antimicrob Chemother 45: Sundsfjord A, Simonsen GS, Courvalin P (2001) Human infections caused by glycopeptideresistant Enterococcus spp: Are they a zoonosis? Clin Microbiol Infect 7(Suppl 4): Bogo Jensen L, Willems AE, van den Bogaard RJ (2003) Genetic characterization of glycopeptide-resistant enterococci of human and animal origin from mixed pig and poultry farms. APMIS 111: PLoS Medicine
Informing Public Policy on Agricultural Use of Antimicrobials in the United States: Strategies Developed by an NGO
Informing Public Policy on Agricultural Use of Antimicrobials in the United States: Strategies Developed by an NGO Stephen J. DeVincent, DVM, MA Director, Ecology Program Alliance for the Prudent Use of
More informationFrank Møller Aarestrup
Danish Veterinary Laboratory Bacterial populations and resistance development: Intestinal tract of meat animals Frank Møller Aarestrup 12 Antibiotic production 10 Mill. Kg 8 6 4 2 0 50 52 54 56 58 60 62
More informationH.C. Wegener, F.M. Aarestrup, L.B. Jensen, A.M. Hammerum and F. Eager. Danish Veterinary Laboratory Bulowsvej 27, DK-1790 Copenhagen V, Denmark
Journal of Animal and Feed Sciences, 7, 1998, 7-14 The association between the use of antimicrobial growth promoters and development of resistance in pathogenic bacteria towards growth promoting and therapeutic
More informationHuman health impacts of antibiotic use in animal agriculture
Human health impacts of antibiotic use in animal agriculture Beliefs, opinions, and evidence Peter Davies BVSc, PhD College of Veterinary Medicine, University of Minnesota, USA Terminology Antibiotic Compound
More informationDecrease of vancomycin resistance in Enterococcus faecium from bloodstream infections in
AAC Accepted Manuscript Posted Online 30 March 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.00513-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 Decrease of vancomycin
More informationReprinted in the IVIS website with the permission of the meeting organizers
Reprinted in the IVIS website with the permission of the meeting organizers FOOD SAFETY IN RELATION TO ANTIBIOTIC RESISTANCE Scott A. McEwen Department of Population Medicine, Ontario Veterinary College,
More informationAntibiotic Resistance The Global Perspective
Antibiotic Resistance The Global Perspective Scott A. McEwen Department of Population Medicine, University of Guelph, Guelph, ON N1G 2W1; Email: smcewen@uoguleph.ca Introduction Antibiotics have been used
More informationPolicy Brief and Recommendations #5 Misuse of Antibiotics in Food Animal Production. Public Health Consequences of Antibiotic Use for Growth Promotion
Policy Brief and Recommendations #5 Misuse of Antibiotics in Food Animal Production Public Health Consequences of Antibiotic Use for Growth Promotion POLICY BRIEF AND RECOMMENDATIONS #5 MISUSE OF ANTIBIOTICS
More informationAnimal Antibiotic Use and Public Health
A data table from Nov 2017 Animal Antibiotic Use and Public Health The selected studies below were excerpted from Pew s peer-reviewed 2017 article Antimicrobial Drug Use in Food-Producing Animals and Associated
More informationQuestions and answers about methicillin-resistant Staphylococcus aureus (MRSA)
Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA) Updated FAQ, 18 November 2014 Methicillin-resistant Staphylococcus aureus (MRSA) are bacteria which are resistant to certain
More informationEFSA s activities on Antimicrobial Resistance
EFSA s activities on Antimicrobial Resistance CRL-AR, Copenhagen 23 April 2009 Annual Workshop of CRL - AR 1 Efsa s Role and Activities on AMR Scientific advices Analyses of data on AR submitted by MSs
More informationRecommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee
VICH GL27 (ANTIMICROBIAL RESISTANCE: PRE-APPROVAL) December 2003 For implementation at Step 7 - Final GUIDANCE ON PRE-APPROVAL INFORMATION FOR REGISTRATION OF NEW VETERINARY MEDICINAL PRODUCTS FOR FOOD
More informationConsequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationMID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance
Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationAntimicrobial Resistance Acquisition of Foreign DNA
Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple
More informationRaising Awareness for Prudent Use of Antibiotics in Animals
Raising Awareness for Prudent Use of Antibiotics in Animals Position paper of the global Alliance for the Prudent Use of Antibiotics (APUA) Prepared by Mary Wilson, M.D., and Melanie Tam Presented at WHO
More informationIt has been demonstrated that food animals may serve as a reservoir of resistant bacteria and/or resistance genes that may
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 2001, p. 2054 2059 Vol. 45, No. 7 0066-4804/01/$04.00 0 DOI: 10.1128/AAC.45.7.2054 2059.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationTestimony of the Natural Resources Defense Council on Senate Bill 785
Testimony of the Natural Resources Defense Council on Senate Bill 785 Senate Committee on Healthcare March 16, 2017 Position: Support with -1 amendments I thank you for the opportunity to address the senate
More informationDoes Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?
Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs? John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and
More informationAntibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines
Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines Report and Qualitative Risk Assessment by the Committee for Veterinary Medicinal Products Annex III Surveillance
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of Change in the approach to the administration of empiric antimicrobial therapy Increased
More informationPreventing Antibiotic Resistance: The Next Step
By Jeffrey B Ritterman, MD Abstract There is universal agreement that the emergence of antibioticresistant bacteria is a significant health problem, leading to preventable morbidity and mortality. Kaiser
More informationEFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA
EFSA s activities on Antimicrobial resistance in the food chain Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA EFSA IS The reference body for risk assessment of food and feed in the European Union. Its
More informationOrigins of Resistance and Resistance Transfer: Food-Producing Animals.
Origins of Resistance and Resistance Transfer: Food-Producing Animals. Chris Teale, AHVLA. Origins of Resistance. Mutation Brachyspira hyodysenteriae and macrolide and pleuromutilin resistance. Campylobacter
More informationData for action The Danish approach to surveillance of the use of antimicrobial agents and the occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark 2 nd edition,
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationJune 12, For animal antibiotics, the safety assessment is more stringent than that for human antibiotics in three ways:
June 12, 2012 Honorable Louise Slaughter Member of Congress 2469 Rayburn House Office Building Washington, DC 20515 Dear Congresswoman Slaughter: We are aware of the letters you sent in February to establishments
More informationInformation note regarding the Danish and EU restrictions of non-therapeutical use of antibiotics for growth promotion
12.08.2009 Information note regarding the Danish and EU restrictions of non-therapeutical use of antibiotics for growth promotion Denmark is a major animal food producer in Europe, and the worlds largest
More informationEnterococci of animal origin and their significance for public health
REVIEW 10.1111/j.1469-0691.2012.03829.x Enterococci of animal origin and their significance for public health A. M. Hammerum Department of Microbiological Surveillance and Research, Statens Serum Institut,
More informationUPDATE ON DEMONSTRATED RISKS IN HUMAN MEDICINE FROM RESISTANT PATHOGENS OF ANIMAL ORIGINS
UPDATE ON DEMONSTRATED RISKS IN HUMAN MEDICINE FROM RESISTANT PATHOGENS OF ANIMAL ORIGINS OIE global Conference on the Responsible and Prudent use of Antimicrobial Agents for Animals Paris (France), 13
More informationQUINUPRISTIN-DALFOPRISTIN RESISTANT E. FAECIUM ON CHICKEN AND IN HUMAN STOOL SPECIMENS
RESISTANT E. FAECIUM ON CHICKEN AND IN HUMAN STOOL SPECIMENS RESISTANT ENTEROCOCCUS FAECIUM ON CHICKEN AND IN HUMAN STOOL SPECIMENS L. CLIFFORD MCDONALD, M.D., SHANNON ROSSITER, M.P.H., CONSTANCE MACKINSON,
More informationGlobal Overview on Antibiotic Use Policies in Veterinary Medicine
Global Overview on Antibiotic Use Policies in Veterinary Medicine Dr Shabbir Simjee Global Regulatory & Technical Advisor Microbiology & Antimicrobials Elanco Animal Health Basingstoke, England simjeess@elanco.com
More informationRandall Singer, DVM, MPVM, PhD
ANTIBIOTIC RESISTANCE Randall Singer, DVM, MPVM, PhD Associate Professor of Epidemiology Department of Veterinary and Biomedical Sciences University of Minnesota Overview How does resistance develop? What
More informationDANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme
DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme Hanne-Dorthe Emborg Department of Microbiology and Risk Assessment National Food Institute, DTU Introduction The DANMAP
More informationMRSA found in British pig meat
MRSA found in British pig meat The first evidence that British-produced supermarket pig meat is contaminated by MRSA has been found in new research commissioned by The Alliance to Save Our Antibiotics
More informationThe Honorable Thomas R. Frieden, MD, MPH Director, Centers for Disease Control and Prevention 1600 Clifton Rd, MS D-14 Atlanta, GA 30333
The Center for a Livable Future June 29, 2010 The Honorable Thomas R. Frieden, MD, MPH Director, Centers for Disease Control and Prevention 1600 Clifton Rd, MS D-14 Atlanta, GA 30333 The Honorable Anthony
More informationApproved by the Food Safety Commission on September 30, 2004
Approved by the Food Safety Commission on September 30, 2004 Assessment guideline for the Effect of Food on Human Health Regarding Antimicrobial- Resistant Bacteria Selected by Antimicrobial Use in Food
More informationPolicy Brief and Recommendations #4 Misuse of Antibiotics in Food Animal Production. Antibiotic Misuse in Food Animals Time for Change
Policy Brief and Recommendations #4 Misuse of Antibiotics in Food Animal Production Antibiotic Misuse in Food Animals Time for Change POLICY BRIEF AND RECOMMENDATIONS #4 MISUSE OF ANTIBIOTICS IN FOOD ANIMAL
More informationVETERINARY DRUG RESIDUES IN FOOD-ANIMAL PRODUCTS: A GLOBAL PUBLIC HEALTH CONCERN
VETERINARY DRUG RESIDUES IN FOOD-ANIMAL PRODUCTS: A GLOBAL PUBLIC HEALTH CONCERN Muheet¹, Ifat Ashraf¹, A.Muhee¹ Division of Clinical Veterinary Medicine, Ethics & Jurisprudence, SKUAST-K, Shuhama, Alusteng,
More informationQuantitative human health risk assessments of antimicrobial use in animals and selection of resistance: a review of publicly available reports
Rev. sci. tech. Off. int. Epiz., 2012, 31 (1), 261-276 Quantitative human health risk assessments of antimicrobial use in animals and selection of resistance: a review of publicly available reports S.A.
More informationRisk management of antimicrobial use and resistance from food-producing animals in Denmark
Risk management of antimicrobial use and resistance from food-producing animals in Denmark A contribution to the joint FAO/WHO/OIE Expert Meeting on Critically Important Antimicrobials, Rome, Italy. 17-21
More informationEPIDEMIOLOGY OF CAMPYLOBACTER IN IRELAND
EPIDEMIOLOGY OF CAMPYLOBACTER IN IRELAND Table of Contents Acknowledgements 3 Summary 4 Introduction 5 Case Definitions 6 Materials and Methods 7 Results 8 Discussion 13 References 14 Epidemiology of Campylobacteriosis
More informationActive Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.
Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted
More informationAntibiotic Use in the Food Supply and Connection with Antibiotic Resistance
Antibiotic Use in the Food Supply and Connection with Antibiotic Resistance by Jessica Moehling and Stephanie Send February 11th, 2016 Outline Objectives Mechanism Behind Antibiotic Resistance History
More informationCampylobacter infections in EU/EEA and related AMR
Campylobacter infections in EU/EEA and related AMR Therese Westrell, ECDC EURL Campylobacter workshop, Uppsala, Sweden, 9 October 2018 Zoonoses Zoonotic infections in the EU, 2016 Campylobacteriosis (N
More informationCampylobacter species
ISSUE NO. 1 SEPTEMBER 2011 1. What are Campylobacter spp.? Campylobacter spp. are microaerophilic, Gram-negative, spiral shaped cells with corkscrew-like motility. They are the most common cause of bacterial
More informationFACT SHEETS. On the Danish restrictions of non-therapeutical use of antibiotics for growth promotion and its consequences
12 July 2010 FACT SHEETS On the Danish restrictions of non-therapeutical use of antibiotics for growth promotion and its consequences Denmark is a major livestock producer in Europe, and the worlds largest
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationLA-MRSA in the Netherlands: the past, presence and future.
LA-MRSA in the Netherlands: the past, presence and future. Prof. Jaap Wagenaar DVM, PhD With input from Prof. Jan Kluytmans MD, PhD Department of Infectious Diseases and Immunology, Faculty of Veterinary
More informationProceedings of. The 15 th Chulalongkorn University Veterinary Conference CUVC 2016: Research in Practice. April 20-22, 2016 Bangkok, Thailand
Proceedings of The 15 th Chulalongkorn University Veterinary Conference CUVC 2016: Research in Practice April 20-22, 2016 Bangkok, Thailand Organized by Faculty of Veterinary Science Chulalongkorn University
More informationAntibiotic Symposium National Institute of Animal Agriculture Atlanta, Georgia
Antibiotic Symposium National Institute of Animal Agriculture Atlanta, Georgia November 3, 2015 Robert Tauxe, MD, MPH Deputy Director, Division of Foodborne, Waterborne and Environmental Diseases National
More information2 nd UK-Russia Round Table on AMR. Christopher Teale, Animal and Plant Health Agency. Moscow, st February 2017.
2 nd UK-Russia Round Table on AMR. Christopher Teale, Animal and Plant Health Agency. Moscow, 20-21 st February 2017. Veterinary Approaches and Priorities. Indicator organisms (commensals) E. coli enterococci
More informationAntimicrobial Resistance Food Animal Antibiotic Use
Antimicrobial Resistance Food Animal Antibiotic Use H. Scott Hurd DVM, PhD College of Veterinary Medicine, Department of Production Animal Medicine Iowa State University, Ames IA 50011, 515-294-7905. shurd@iastate.edu
More informationAntimicrobial Resistance Monitoring Program in Food-Producing Animals in Japan
93,0 * Antimicrobial Resistance Monitoring Program in Food-Producing Animals in Japan Tetsuo ASAI* National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, + +/ + Tokura,
More informationAntibiotic resistance and the human-animal interface: Public health concerns
Antibiotic resistance and the human-animal interface: Public health concerns Antibiotic Use and Resistance Moving forward through shared stewardship National Institute for Animal Agriculture Atlanta, Georgia
More informationGlycopeptide Resistant Enterococci (GRE) Policy IC/292/10
BASINGSTOKE AND NORTH HAMPSHIRE NHS FOUNDATION TRUST Glycopeptide Resistant Enterococci (GRE) Policy IC/292/10 Supersedes: IC/292/07 Owner Name Dr Nicki Hutchinson Job Title Consultant Microbiologist,
More informationAntimicrobial Use and Antimicrobial Resistance in Relation to the Canadian Pork Sector Presented by Jorge Correa Pork Committee Banff May 2013
Antimicrobial Use and Antimicrobial Resistance in Relation to the Canadian Pork Sector Presented by Jorge Correa Pork Committee Banff May 2013 Part of the Slides were extracted from a Paul Dick presentation
More informationChanging Practices to Reduce Antibiotic Resistance
Changing Practices to Reduce Antibiotic Resistance Jean E. McLain, Research Scientist and Assistant Dean University of Arizona College of Agriculture and Life Sciences and Department of Soil, Water and
More informationInterventions Aimed at Reducing Antimicrobial Usage and Resistance in Production Animals in Denmark
Interventions Aimed at Reducing Antimicrobial Usage and Resistance in Production Animals in Denmark Vibe Dalhoff Andersen, DVM, National Food Institute, Technical University of Denmark; Tine Hald, DVM,
More informationAntibiotic Resistance
Antibiotic Resistance ACVM information paper Background Within New Zealand and internationally, concerns have been raised about an association between antibiotics used routinely to protect the health of
More informationThe EFSA s BIOHAZ Panel perspective on food microbiology and hygiene
The EFSA s BIOHAZ Panel perspective on food microbiology and hygiene Dr Eirini Tsigarida Unit of Biological Hazards BIOHAZ Unit: Marta Hugas, Bart Goossens, Tobin Robinson, Fulvio Barizzone, Luis Vivas-
More informationTaking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms
Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms Nimalie D. Stone, MD,MS Division of Healthcare Quality Promotion National
More informationIs biocide resistance already a clinical problem?
Is biocide resistance already a clinical problem? Stephan Harbarth, MD MS University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland Important points Biocide resistance exists Antibiotic
More informationAntibiotic Resistance and Hospital-Acquired Infection Prof. Carl T. Bergstrom
Antibiotic Resistance Carl T. Bergstrom Department of Biology University of Washington 1 In the first nine months of 2005, Pennsylvania hospitals reported: 13,711 hospital acquired infections Pennsyl vania
More informationQuinupristin-dalfopristin Resistance in Gram-positive Bacteria: Experience from a Tertiary Care Referral Center in North India
Original Article 117 Quinupristin-dalfopristin Resistance in Gram-positive Bacteria: Experience from a Tertiary Care Referral Center in North India Antariksh Deep, M.D.*, Nidhi Goel, M.D.*, Rama Sikka,
More informationESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED
ESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED Caroline Pissetti 1, Jalusa Deon Kich 2, Heather K. Allen 3, Claudia Navarrete
More informationAntimicrobial use in poultry: Emerging public health problem
Antimicrobial use in poultry: Emerging public health problem Eric S. Mitema, BVM, MS, PhD CPD- Diagnosis and Treatment of Poultry Diseases FVM, CAVS, 6 th. August, 2014 AMR cont Antibiotics - Natural or
More informationThe ways in which bacteria resist antibiotics
International Journal of Risk & Safety in Medicine 17 (2005) 111 116 111 IOS Press The ways in which bacteria resist antibiotics Dan I. Andersson Uppsala University, Department of Medical Biochemistry
More informationGeneral Certificate of Education Advanced Level Examination June 2015
General Certificate of Education Advanced Level Examination June 2015 Science in Society SCIS4 Unit 4 Case Study of a Scientific Issue Monday 22 June 2015 9.00 am to 10.30 am For this paper you must have:
More informationProceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium
www.ivis.org Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium May 17-20, 2015 Fort Collins, CO, USA Reprinted in the IVIS website with the permission
More informationJoint scientific report of ECDC, EFSA and EMEA on meticillin resistant Staphylococcus aureus (MRSA) in livestock, companion animals and food 1.
16 June 2009 Joint scientific report of ECDC, EFSA and EMEA on meticillin resistant Staphylococcus aureus (MRSA) in livestock, companion animals and food 1. Summary of the scientific Opinion of the Panel
More informationScreening programmes for Hospital Acquired Infections
Screening programmes for Hospital Acquired Infections European Diagnostic Manufacturers Association In Vitro Diagnostics Making a real difference in health & life quality June 2007 HAI Facts Every year,
More informationKeeping Antibiotics Working: Nursing Leadership in Action
Keeping Antibiotics Working: Nursing Leadership in Action Pat McLaine, DrPH, MPH, RN Robyn Gilden, PhD, RN Department of Family and Community Health Maryland Nurses Association October 2016 US 2 million
More informationPreventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal
Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier
More informationUnderstanding and prevention of transmission of antibiotic resistance between bacterial populations and One Health reservoirs
Priority Topic D - Transmission Understanding and prevention of transmission of antibiotic resistance between bacterial populations and One Health reservoirs The overarching goal of this priority topic
More informationWhat Canadian vets need to know and explain about antimicrobial resistance
What Canadian vets need to know and explain about antimicrobial resistance By John F. Prescott, MA, VetMB, PhD Major changes are underway regarding how agricultural use of antibiotics is regulated in food
More informationRisk management approaches to antimicrobial resistance in the U.S. and abroad
Risk management approaches to antimicrobial resistance in the U.S. and abroad Expectations, results and conundrums H. Morgan Scott DVM, PhD E.J. Frick Professor of Veterinary Medicine Department of Diagnostic
More informationHuman Diseases Caused by Foodborne Pathogens of Animal Origin
SUPPLEMENT ARTICLE Human Diseases Caused by Foodborne Pathogens of Animal Origin Morton N. Swartz Massachusetts General Hospital, Boston Many lines of evidence link antimicrobial-resistant human infections
More informationGlobal Food Supply Chain Risks. Antibiotics and the emergence of antibiotic-resistant bacteria in the food chain
Global Food Supply Chain Risks Antibiotics and the emergence of antibiotic-resistant bacteria in the food chain Antibiotics and the emergence of antibiotic-resistant bacteria in the food chain Antibiotic-resistant
More informationTESTIMONY OF. Lyle Vogel, DVM, MPH, DACVPM. Assistant Executive Vice President. American Veterinary Medical Association.
TESTIMONY OF Lyle Vogel, DVM, MPH, DACVPM Assistant Executive Vice President American Veterinary Medical Association Concerning Antimicrobial Resistance Before the Senate Committee on Health, Education,
More informationANNEX. to the COMMISSION IMPLEMENTING DECISION
EUROPEAN COMMISSION Brussels, 30.4.2015 C(2015) 3024 final ANNEX 1 ANNEX to the COMMISSION IMPLEMENTING DECISION on the adoption of the multiannual work programme for 2016-2017 for the implementation of
More informationESCMID Online Lecture Library. by author
ESCMID Postgraduate Technical Workshop Antimicrobial susceptibility testing and surveillance of resistance in Gram-positive cocci: laboratory to clinic Current epidemiology of invasive enterococci in Europe
More informationProject Summary. Emerging Pathogens in US Cattle
Project Summary Emerging Pathogens in US Cattle Principal Investigators: Jeffrey LeJeune and Gireesh Rajashekara Food Animal Health Research Program The Ohio Agricultural Research and Development Center
More informationWhat is antimicrobial resistance?
What is antimicrobial resistance? Gérard MOULIN gerard.moulin@anses.fr French agency for food, environmental and occupationnal safety National agency for veterinary Medicinal Products BP 90203-35302 FOUGERES
More informationUniversity of Groningen
University of Groningen Selective decontamination of the digestive tract: all questions answered? Bonten, MJM; Joore, HCA; de Jongh, BM; Kluytmans, J; Kuijper, EJ; van Leeuwen, HJ; de Smet, AMGA; Vandenbroucke-Grauls,
More informationARCH-Vet. Summary 2013
Federal Department of Home Affairs FDHA FSVO ARCH-Vet Report on sales of antibiotics in veterinary medicine and antibiotic resistance monitoring of livestock in Switzerland Summary 2013 Published by Federal
More informationDANMAP and VetStat. Monitoring resistance and antimicrobial consumption in production animals
DANMAP and VetStat Monitoring resistance and antimicrobial consumption in production animals Flemming Bager Head Division for Risk Assessment and Nutrition Erik Jacobsen Danish Veterinary and Food Administration
More informationKey words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin
Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin Table 1 Detection rate of Campylobacter from stool samples taken from sporadic diarrheic patients Table 2 Detection rates of Campylobacter
More informationTERMS OF REFERENCE (June 1997, Reviewed 17/9/97) BACKGROUND. (opinion expressed on 05 February 1998)
Report of the Scientific Committee for Animal Nutrition on the Efficacy and Risk for Users of the Therapeutic Macrolides Antibiotics Tylosin and Spiramycin Used as Feed Additives (opinion expressed on
More informationTEXTS ADOPTED Provisional edition. P8_TA-PROV(2018)0429 Animal welfare, antimicrobial use and the environmental impact of industrial broiler farming
European Parliament 204-209 TEXTS ADOPTED Provisional edition P8_TA-PROV(208)0429 Animal welfare, antimicrobial use and the environmental impact of industrial broiler farming European Parliament resolution
More informationEFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.
EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication. Dr. Ernesto Liebana BIOHAZ Team Leader European Food Safety Authority (EFSA) EFSA
More informationInternational Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals
International Food Safety Authorities Network (INFOSAN) 7 March 2008 INFOSAN Information Note No. 2/2008 - Antimicrobial Resistance Antimicrobial Resistance from Food Animals SUMMARY NOTES Antimicrobial
More informationThe Responsible and Prudent use of Antimicrobials on Irish Pig Farms. Denis Healy
The Responsible and Prudent use of Antimicrobials on Irish Pig Farms Denis Healy Antimicrobials/ Antibiotics - history Developed from the 1940s Treat Bacterial infections human, animal Intensive farming
More informationMulti-Drug Resistant Organisms (MDRO)
Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause
More informationDoes the use of antibiotics in food animals pose a risk to human health? A critical review of published data
Journal of Antimicrobial Chemotherapy (2004) 53, 28 52 DOI: 10.1093/jac/dkg483 Advance Access publication 4 December 2003 Does the use of antibiotics in food animals pose a risk to human health? A critical
More informationEC Workshop on scientific advice from AMEG
EC Workshop on scientific advice from AMEG Brussels, 26 Nov 2015 Session 2: Antibiotic Categorisation AMEG Q2 Karolina Törneke / Helen Jukes Liability disclaimer: The views or positions expressed in this
More informationWhat bugs are keeping YOU up at night?
What bugs are keeping YOU up at night? Barbara DeBaun, RN, MSN, CIC 26 th Annual Medical Surgical Nursing Conference South San Francisco, CA April 15, 2016 Objectives Describe the top three infectious
More informationHealthcare-associated Infections Annual Report March 2015
March 2015 Healthcare-associated Infections Annual Report 2009-2014 TABLE OF CONTENTS SUMMARY... 1 MRSA SURVEILLANCE RESULTS... 1 CDI SURVEILLANCE RESULTS... 1 INTRODUCTION... 2 METHICILLIN-RESISTANT
More informationANNEX. to the. Commission Implementing Decision
EUROPEAN COMMISSION Brussels, 2.5.2017 C(2017) 2841 final ANNEX 1 ANNEX to the Commission Implementing Decision on the adoption of the multiannual work programme for 2018, 2019 and 2020 for the implementation
More information